Anavex Life Sciences AVXL
NASDAQ AVXL
$1.82 -0.07 (-3.70%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anavex Life Sciences (AVXL) Cash from Investing Activities (2013 - 2014)

Updated

Anavex Life Sciences' Cash from Investing Activities came in at -$688.00 for fiscal Q4 2014 (quarter ended Sep 30, 2014).

Analysis

Anavex Life Sciences (AVXL) Cash from Investing Activities (2013 - 2014) Analysis & Trends

For FY2014 (ended Sep 30, 2014), Anavex Life Sciences' Cash from Investing Activities was -$3,015.

  • Going back by fiscal year, Cash from Investing Activities was -$3,310 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Anavex Life Sciences 168.71 Mn -311.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 -688.00
Dec 31, 2013 -2,327.00
API Access

Anavex Life Sciences Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=AVXL&period=max&api_key=YOUR_API_KEY